- Projects & figures
- News & Events
- Managing your project
- About ERC
Bacteria fight big. When they meet competitors, they are as aggressive and bloodthirsty as they come. ERC grantee Kevin Foster studies how bacteria wage war against each other. His aim is to understand what led to the evolution of such extreme competitive behaviours, and how to exploit them for our own health.
To this day, little is known about sudden unexpected death in epilepsy. Only very few cases have actually been witnessed or monitored. But that might be about to change. Wearable electronics could provide just the solution researchers have been looking for.
Diseases affecting the retina cause one quarter of worldwide blindness. To date, there are no treatments to restore lost retinal cells and visual function, making it urgent to find new therapeutic approaches. Can stem cells be the solution? Prof. Majlinda Lako aims at growing artificial replicas of the human retina using stem cells.
ELECTION SERIES #8
State regulation of civil society has grown consistently over the past decade, raising concerns over the eroding role of the latter in shaping democratic decision-making. The ERC-funded STATORG project has investigated this issue across several long-lived democracies, considering country-specific regulations and how these affect civil society organisations.
ELECTION SERIES #6
Developed by the Oxford Internet Institute with EU funding, the junk news aggregator (JNA) interactively displays articles from unreliable sources as they spread on Facebook. Researchers hope the tool will help tackle the growing phenomenon of misinformation on social media.
ELECTION SERIES #3
The traditional pencil-and-paper method to mark your vote in the polling booth has been gradually replaced by electronic voting machines in many countries, in Europe and beyond. Ensuring the security of electronic voting machines and quelling fears of vote-rigging have become ever more important. One ERC-funded researcher has been working tirelessly to develop such an e-voting system through two projects, SEEVS and its follow-up SEEVCA.
Every day thousands of people across Europe are working together to keep EU citizens safe from challenges to do with health, the environment, crime, terrorism, migration and the economy.
“Once lost is lost", one may think, especially if the piece of forgotten patrimony is an opera from 1850 that is “incomplete, too fragmented and irretrievable”, according to the experts. Except for Dr. David Trippet: like an art restorer holding fine paintbrushes, he has dedicated three years of intensive research to retrieve the unborn opera, bringing the music and libretto back to life 170 years later.
According to the World Health Organisation (WHO), more than 1.9 billion adults were overweight in 2016. Of these, over 650 million were obese and therefore at a higher risk of developing cardiovascular diseases, diabetes, musculoskeletal disorders and some forms of cancers. In one of the largest studies of its kind, researchers have looked into the reasons why some people are more likely to gain weight while others manage to stay thin.
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancer
Pancreatic cancer is the 4th leading cause of death by cancer in Europe. It has a very low survival rate with less than 1 per cent of sufferers surviving for 10 or more years. Over the last 40 years the survival rate has not significantly changed and finding an effective therapy has become a pressing challenge in cancer research. A team based at Imperial College London led by Armando Del Río Hernández, has now demonstrated that a well-known drug could be effective to fight this deadly and other forms of cancer, such as liver cancer.